Transcriptomics

Dataset Information

0

CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC


ABSTRACT: In neutrophil-enriched triple-negative breast cancer (TNBC) models, CREB binding protein (CBP)/P300 bromodomain (BRD) inhibition reduces tumor growth and systemic neutrophil accumulation while stimulating an antitumor immune response. This improves standard-of-care therapies, suggesting a potential therapeutic benefit of CBP/P300 BRD inhibitors for neutrophil-enriched TNBC.

ORGANISM(S): Mus musculus

PROVIDER: GSE264627 | GEO | 2024/09/03

REPOSITORIES: GEO

Similar Datasets

| PRJNA358160 | ENA
| PRJEB41497 | ENA
2023-05-08 | PXD040835 | Pride
2018-06-10 | PXD005252 | Pride
| PRJEB41478 | ENA
2020-12-17 | PXD019708 | Pride
2020-04-03 | PXD015694 | Pride
2017-12-11 | GSE101537 | GEO
2018-06-13 | GSE92613 | GEO
2014-09-29 | E-GEOD-54452 | biostudies-arrayexpress